Core Insights - The 17th China Bioindustry Conference showcased cutting-edge technologies in the biofield, emphasizing the theme "Biotechnology Empowers the Future, Biomanufacturing Reshapes the World" [1] - The conference serves as a significant booster for China's bioindustry development, facilitating deep connections between industry, academia, and research to accelerate technology transfer and resource integration [1] Company Highlights - Shanghai United Imaging Healthcare Co., Ltd. presented the world's first 5.0T whole-body MRI system, uMR Jupiter 5T, which offers high-definition imaging for precise diagnosis and seamless integration of research and clinical applications [1] - Wuhan Heyuan Biotechnology Co., Ltd. introduced the first recombinant human albumin injection derived from rice, which alleviates reliance on imported products and is set to achieve an annual production capacity of 12 million bottles by 2026 [2] - BGI Life Sciences Research Institute announced the Stereo-seq V2 technology, a groundbreaking spatial transcriptomics method compatible with FFPE samples, enabling high-resolution analysis of host and microbial interactions in clinical settings [3] Industry Trends - The bioindustry is transitioning from "quantitative accumulation" to "qualitative leap," focusing on core technology breakthroughs, product quality upgrades, and enhancing supply chain resilience [7] - Innovations in synthetic biology and gene editing are driving rapid growth in biomanufacturing, with artificial intelligence playing a crucial role in life science advancements [7] - Future developments in the bioindustry are expected to concentrate on cutting-edge fields such as synthetic biology and brain science to build core competitiveness [7]